Dealing with pain has become increasingly challenging for columnist Robin Stemple, who struggles to find relief from the hurt ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

News from around the community includes items from Lemont, Elmwood Park, Franklin Park, Oak Park, River Forest, Elmhurst and ...

Proposed cuts to the National Institutes of Health and the National Science Foundation “would cause immense and largely ...

During the month of July, the ‘Dumbbell Dozen’, led by West Mersea local Colin Morgan, 67, will attempt to lift 1,000 tonnes ...

After a decade-long search for answers to her difficulties with walking and other physical activities, Joanne Dalessandro of ...

Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.

WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.

Muscular Dystrophy UK, the leading charity for more than 110,000 children and adults in the UK living with one of over 60 ...